Recondyl, created in 1994 (Germany), from 223 sister brands and 17478 competing brands. Recondyl is owned by Daiichi Sankyo, listed on the stock exchange of Francfort The International Securities Identification Number (ISIN) of Daiichi Sankyo is JP3475350009. Recondyl belongs to the Drug Manufacturers business sector.